Table 1 Clinicopathological characteristics of patients
From: Surgical choice of non-small cell lung cancer with unexpected pleural dissemination intraoperatively
Variables | Open-close | Tumor resection | P value |
|---|---|---|---|
Number of patients, n | 65 | 104 | - |
Age, year (mean ± SD) | 57.7 ± 9.5 | 56.9 ± 11.2 | 0.664 |
Male gender, n (%) | 38 (58.5) | 52 (50.0) | 0.361 |
Smoking status, n (%) | Â | Â | 0.433 |
 Non-smoker | 45 (69.2) | 79 (76.0) |  |
 Smoker | 20 (30.8) | 25 (24.0) |  |
Comorbidities, n (%) | Â | Â | 0.781 |
 Cardiovascular | 12 (18.5) | 20 (19.2) |  |
 Diabetes | 3 (4.6) | 8 (7.7) |  |
 Hepatitis | 2 (3.1) | 0 (0.0) |  |
 Other malignancies | 1 (1.5) | 1 (1.0) |  |
Pathological type, n (%) | Â | Â | 0.340 |
 Adeno | 54 (83.1) | 92 (88.5) |  |
 Squamous | 4 (6.2) | 7 (6.7) |  |
 Other | 7 (10.8) | 5 (4.8) |  |
Right-sided tumor, n(%) | 33 (50.8) | 59 (56.7) | 0.550 |
Clinical T stage, n (%) | Â | Â | 0.084 |
 1 | 27 (41.5) | 57 (54.8) |  |
 2 | 21 (32.3) | 35 (33.7) |  |
 3 | 7 (10.8) | 6 (5.8) |  |
 4 | 10 (15.4) | 6 (5.8) |  |
Clinical N stage, n (%) | Â | Â | 0.677 |
 0 | 36 (55.4) | 61 (58.6) |  |
 1 | 4 (6.1) | 9 (8.6) |  |
 2 | 25 (38.5) | 34 (32.7) |  |
Gene mutation, n (%) | Â | Â | 0.007 |
 EGFR/ALK | 23 (35.4) | 59 (56.7) |  |
 No/Unknown | 42 (64.6) | 45 (43.3) |  |
Neoadjuvant treatment, n (%) | Â | Â | Â |
 Chemotherapy | 2 (3.1) | 6 (5.8) | 0.668 |
 Targeted therapy | 0 (0.0) | 1 (1.0) | 1.000 |
Adjuvant treatment, n (%) | Â | Â | Â |
 Chemotherapy | 49 (75.4) | 84 (80.8) | 0.523 |
 Targeted therapy | 20 (35.1) | 44 (45.4) | 0.212 |